Interleukin-4 Inhibition of Interleukin-1-induced Expression of Matrix Metalloproteinase-3 (MMP-3) is Independent of Lipoxygenase and PPARgamma Activation in Human Gingival Fibroblasts

Overview

Journal BMC Mol Biol

Publisher Biomed Central

Specialty Molecular Biology

Date 2007 Feb 27

PMID 17319946

Citations 3

Authors

Denise Stewart

Masoud Javadi

Mariah Chambers

Chad Gunsolly

Grzegorz Gorski

Ruth C Borghaei

Affiliations

Soon will be listed here.

Abstract

Background: Interleukin 4 (IL-4) has been shown to suppress interleukin-1 (IL-1) induced expression of matrix metalloproteinase-3 (MMP-3) in human synovial and gingival fibroblasts, but the mechanism of suppression has not been determined. Activators of peroxisome proliferator-activated receptor-gamma (PPARgamma) have been shown to inhibit cytokine induced expression of MMPs in other cell types, and IL-4 has been shown to activate PPARgamma by stimulating production of ligands through the lipoxygenase pathway. It has been suggested that PPARgamma may inhibit expression of MMPs by competing with transcription factor AP-1 for binding to a putative composite binding element in the promoters. The objective of this study was to determine whether the suppressive effects of IL-4 on the IL-1 induced expression of MMP-3 involve activation of lipoxygenase and/or PPARgamma.

Results: Western blotting revealed the presence of PPARgamma in nuclear extract of HGF. IL-1 induced binding of nuclear extract to the putative composite PPRE/AP-1 site was diminished in the presence of pioglitazone, but there was no evidence of any change in the composition of the retarded complexes, and no evidence of PPARgamma binding to this site. Nordihydroguaiaretic acid (NDGA), a non-selective lipoxygenase inhibitor, and MK886, a specific inhibitor of 5-lipoxygenase, induced MMP-3 expression synergistically with IL-1. However IL-4 was still able to inhibit MMP-3 expression in the presence of NDGA or MK886 and IL-1. Activation of PPARgamma with pioglitazone not only failed to inhibit IL-1 induced expression of MMP-3 mRNA, but rather super-induced MMP-3 in the presence of IL-1. PPARgamma antagonist GW9662 failed to abolish the suppressive effects of IL-4. Another PPARgamma activator, 15-deoxy-Delta12,14prostaglandin J2 (15dPGJ2), also super-induced MMP-3 mRNA, and this was due at least in part to increased transcription.

Conclusion: IL-4 suppression of IL-1-induced MMP-3 expression in HGF is independent of lipoxygenase activity and activation of PPARgamma. Super-induction of MMP-3 by pioglitazone may have important implications for patients using pioglitazone to treat type II diabetes in the presence of chronic inflammation.

Citing Articles

Cordycepin-induced Keratinocyte Secretome Promotes Skin Cell Regeneration.

Kunhorm P, Chaicharoenaudomrung N, Noisa P In Vivo. 2023; 37(2):574-590.

PMID: 36881050 PMC: 10026670. DOI: 10.21873/invivo.13116.

The associations between serum vascular endothelial growth factor, tumor necrosis factor and interleukin 4 with the markers of blood-brain barrier breakdown in patients with paraneoplastic neurological syndromes.

Michalak S, Kalinowska-Lyszczarz A, Rybacka-Mossakowska J, Zaborowski M, Kozubski W J Neural Transm (Vienna). 2018; 126(2):149-158.

PMID: 30374596 PMC: 6373237. DOI: 10.1007/s00702-018-1950-9.

IL-4 inhibition of IL-1 induced Matrix metalloproteinase-3 (MMP-3) expression in human fibroblasts involves decreased AP-1 activation via negative crosstalk involving of Jun N-terminal kinase (JNK).

Chambers M, Kirkpatrick G, Evans M, Gorski G, Foster S, Borghaei R Exp Cell Res. 2013; 319(10):1398-408.

PMID: 23608488 PMC: 3757497. DOI: 10.1016/j.yexcr.2013.04.010.

References

Haerian A, Adonogianaki E, Mooney J, Docherty J, Kinane D . Gingival crevicular stromelysin, collagenase and tissue inhibitor of metalloproteinases levels in healthy and diseased sites. J Clin Periodontol. 1995; 22(7):505-9. DOI: 10.1111/j.1600-051x.1995.tb00797.x. View

Prontera C, Crescenzi G, Rotilio D . Inhibition by Interleukin-4 of stromelysin expression in human skin fibroblasts: role of PKC. Exp Cell Res. 1996; 224(1):183-8. DOI: 10.1006/excr.1996.0126. View

Sun D, Funk C . Disruption of 12/15-lipoxygenase expression in peritoneal macrophages. Enhanced utilization of the 5-lipoxygenase pathway and diminished oxidation of low density lipoprotein. J Biol Chem. 1996; 271(39):24055-62. View

Dolhain R, van der Heiden A, ter Haar N, Breedveld F, Miltenburg A . Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum. 1996; 39(12):1961-9. DOI: 10.1002/art.1780391204. View

Aiba T, Akeno N, Kawane T, Okamoto H, Horiuchi N . Matrix metalloproteinases-1 and -8 and TIMP-1 mRNA levels in normal and diseased human gingivae. Eur J Oral Sci. 1996; 104(5-6):562-9. DOI: 10.1111/j.1600-0722.1996.tb00142.x. View

Parsons S, Watson S, Brown P, Collins H, Steele R . Matrix metalloproteinases. Br J Surg. 1997; 84(2):160-6. View

Yamamoto M, Fujihashi K, Hiroi T, McGhee J, Van Dyke T, Kiyono H . Molecular and cellular mechanisms for periodontal diseases: role of Th1 and Th2 type cytokines in induction of mucosal inflammation. J Periodontal Res. 1997; 32(1 Pt 2):115-9. DOI: 10.1111/j.1600-0765.1997.tb01391.x. View

Nemoto O, Yamada H, Kikuchi T, Shinmei M, Obata K, Sato H . Suppression of matrix metalloproteinase-3 synthesis by interleukin-4 in human articular chondrocytes. J Rheumatol. 1997; 24(9):1774-9. View

Park S, Lee D, Yang C . Inhibition of fos-jun-DNA complex formation by dihydroguaiaretic acid and in vitro cytotoxic effects on cancer cells. Cancer Lett. 1998; 127(1-2):23-8. DOI: 10.1016/s0304-3835(97)00543-0. View

10.

Jorgensen C, Apparailly F, Couret I, Canovas F, Jacquet C, Sany J . Interleukin-4 and interleukin-10 are chondroprotective and decrease mononuclear cell recruitment in human rheumatoid synovium in vivo. Immunology. 1998; 93(4):518-23. PMC: 1364130. DOI: 10.1046/j.1365-2567.1998.00457.x. View

11.

Borghaei R, Rawlings Jr P, Mochan E . Interleukin-4 suppression of interleukin-1-induced transcription of collagenase (MMP-1) and stromelysin 1 (MMP-3) in human synovial fibroblasts. Arthritis Rheum. 1998; 41(8):1398-406. PMC: 1602062. DOI: 10.1002/1529-0131(199808)41:8<1398::AID-ART8>3.0.CO;2-B. View

12.

Borghaei R, Sullivan C, Mochan E . Identification of a cytokine-induced repressor of interleukin-1 stimulated expression of stromelysin 1 (MMP-3). J Biol Chem. 1999; 274(4):2126-31. PMC: 1595537. DOI: 10.1074/jbc.274.4.2126. View

13.

van der Graaff W, Prins A, Niers T, Dijkmans B, van Lier R . Quantitation of interferon gamma- and interleukin-4-producing T cells in synovial fluid and peripheral blood of arthritis patients. Rheumatology (Oxford). 1999; 38(3):214-20. DOI: 10.1093/rheumatology/38.3.214. View

14.

Huang J, Welch J, Ricote M, Binder C, Willson T, Kelly C . Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature. 1999; 400(6742):378-82. DOI: 10.1038/22572. View

15.

Cheung N, Dawes P, Poulton K, Ollier W, Taylor D, Mattey D . High serum levels of pro-matrix metalloproteinase-3 are associated with greater radiographic damage and the presence of the shared epitope in patients with rheumatoid arthritis. J Rheumatol. 2000; 27(4):882-7. View

16.

Inoue H, Tanabe T, Umesono K . Feedback control of cyclooxygenase-2 expression through PPARgamma. J Biol Chem. 2000; 275(36):28028-32. DOI: 10.1074/jbc.M001387200. View

17.

Bondeson J, Brennan F, Foxwell B, Feldmann M . Effective adenoviral transfer of IkappaBalpha into human fibroblasts and chondrosarcoma cells reveals that the induction of matrix metalloproteinases and proinflammatory cytokines is nuclear factor-kappaB dependent. J Rheumatol. 2000; 27(9):2078-89. View

18.

Lijnen H, Arza B, Van Hoef B, Collen D, Declerck P . Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3). J Biol Chem. 2000; 275(48):37645-50. DOI: 10.1074/jbc.M006475200. View

19.

Matsuno H, Yudoh K, Watanabe Y, Nakazawa F, Aono H, Kimura T . Stromelysin-1 (MMP-3) in synovial fluid of patients with rheumatoid arthritis has potential to cleave membrane bound Fas ligand. J Rheumatol. 2001; 28(1):22-8. View

20.

Noe V, Fingleton B, Jacobs K, Crawford H, Vermeulen S, Steelant W . Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci. 2000; 114(Pt 1):111-118. DOI: 10.1242/jcs.114.1.111. View